Adrian Adams
CIK: 0001248144
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)4 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
About ADAMS ADRIAN
ADAMS ADRIAN (SEC CIK 0001248144) files insider reports with the SEC as Director of TALPHERA, INC. (TLPH) and Director of Akebia Therapeutics, Inc. (AKBA).
Signal8 holds 4 ownership filings by ADAMS ADRIAN, all Form 4s, filed between Jun 11, 2025 and Jun 24, 2026. Those filings report 4 transactions, from Jun 10, 2025 to Jun 22, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on ADAMS ADRIAN's filings is in CAMBRIDGE, MA.
Recent filings by ADAMS ADRIAN
Other insiders filing for TALPHERA, INC. (TLPH)
- WAN MARK A, Director
- Todisco Joseph, Director
- JAIN ABHINAV, Director
- HOFFMAN STEPHEN J, Director
- Broadfoot Jill Marie, Director
- Bozilenko Marina, Director